The Role of IL-17A in Mediating Inflammatory Responses and Progression of Neurodegenerative Diseases., PMID:40141149
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders., PMID:39875232
Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing., PMID:39381601
IL-17A-neutralizing antibody ameliorates inflammation and fibrosis in rosacea by antagonizing the CXCL5/CXCR2 axis., PMID:39370827
[Translated article] Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice., PMID:38815679
Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb/C mice., PMID:38310250
IL-17 receptor goes solo in autoimmune inflammation., PMID:37703825
Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation., PMID:37619953
An autonomous activation of interleukin-17 receptor signaling sustains inflammation and promotes disease progression., PMID:37473759
Neuroprotective effect of secukinumab against rotenone induced Parkinson's disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade., PMID:36527875
Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A VHH Domain., PMID:36499233
Interleukin-17 as a potential therapeutic target for chronic pain., PMID:36248896
The dark side of the moon: the immune-mediated adverse events of IL-17A/IL-17R inhibition., PMID:35393910
Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis., PMID:35188599
Expression and activity of IL-17 receptor subunits in human cutaneous cells as targets for anti-IL-17 therapeutic antibodies., PMID:35062060
The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases., PMID:34863654
Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling., PMID:34516780
Metabolic Disorders/Obesity Is a Primary Risk Factor in Hidradenitis Suppurativa: An Immunohistochemical Real-World Approach., PMID:34293747
From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment., PMID:34201664
Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification., PMID:34189826
Intestinal IL-17R Signaling Controls Secretory IgA and Oxidase Balance in Citrobacter rodentium Infection., PMID:33431657
IL-21 Promotes Intestinal Memory IgA Responses., PMID:32859726
Quantitative Proteomic Profile of Psoriatic Epidermis Identifies OAS2 as a Novel Biomarker for Disease Activity., PMID:32849499
RORC overexpression as a sign of Th17 lymphocytes accumulation in multiple myeloma bone marrow., PMID:32707421
IL-17C has a pathogenic role in kidney ischemia/reperfusion injury., PMID:32331702
IL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology., PMID:32174926
Cajanonic acid A regulates the ratio of Th17/Treg via inhibition of expression of IL-6 and TGF-β in insulin-resistant HepG2 cells., PMID:31729529
Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment., PMID:31727784
Blockade of IL-17A/IL-17R Pathway Protected Mice from Sepsis-Associated Encephalopathy by Inhibition of Microglia Activation., PMID:31686986
An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses., PMID:31666991
Serum biomarker analysis in patients with premature ovarian insufficiency., PMID:31629109
IL-17A neutralizing antibody attenuates eosinophilic meningitis caused by Angiostrongylus cantonensis by involving IL-17RA/Traf6/NF-κB signaling., PMID:31415761
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation., PMID:31315067
Immunoglobulin Binding Protein 1 as a Potential Urine Biomarker in Patients with Lupus Nephritis., PMID:31137925
Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris., PMID:31097934
Brodalumab in psoriasis: evidence to date and clinical potential., PMID:31024633
Neutrophils and IL17A mediate flagellar hook protein FlgE-induced mouse acute lung inflammation., PMID:30412932
Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases., PMID:30171358
Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF-κB pathways., PMID:30007092
Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease., PMID:29979986
Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis., PMID:29899748
Artificial Macrocycles as IL-17A/IL-17RA Antagonists., PMID:29750108
IL-17C/IL-17 Receptor E Signaling in CD4+ T Cells Promotes TH17 Cell-Driven Glomerular Inflammation., PMID:29483158
Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis., PMID:29474945
Up-regulation of IL-23 expression in human dental pulp fibroblasts by IL-17 via activation of the NF-κB and MAPK pathways., PMID:29106731
Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB., PMID:31966806
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?, PMID:28765121
IL-17 Promotes Differentiation of Splenic LSK- Lymphoid Progenitors into B Cells following Plasmodium yoelii Infection., PMID:28733485
Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation., PMID:28184939
Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens., PMID:28002842